Last updated: October 20, 2025
Introduction
Patent KR20240036132 pertains to a novel pharmaceutical invention filed in South Korea, focusing on a specific medicinal formulation or process. A detailed examination involves analyzing the patent’s scope—particularly its claims—alongside its positioning within the existing patent landscape. This analysis aims to inform stakeholders on the patent’s strength, potential overlaps, and strategic implications.
1. Patent Overview and Filing Context
Patent KR20240036132 was filed with the Korean Intellectual Property Office (KIPO) and published in 2024. The patent aims to protect a specific drug composition, method of manufacturing, or therapeutic use. Its priority and application dates are critical for assessing novelty and inventive step, though such details are not publicly disclosed until publication.
Key Points:
- Applicant/Assignee: Identifies the patent owner, often a pharmaceutical company or research institution.
- Publication Date: 2024, indicating recent development activity.
- Jurisdiction: South Korea, with potential for territorial extension via PCT applications or national filings elsewhere.
2. Scope and Claims Analysis
a. Claim Structure and Language
The scope of a patent hinges primarily on its claims, which define the legal boundaries of protection:
- Independent Claims: These establish the core inventive concept—such as a novel drug compound, a unique formulation, or a manufacturing method.
- Dependent Claims: These further specify particular embodiments, dosage forms, or auxiliary features that narrow but clarify the invention.
KR20240036132’s claims are predominantly centered on a pharmaceutical composition comprising a specific active pharmaceutical ingredient (API), possibly combined with excipients, or a method of preparing the same.
b. Nature of the Claims
Without accessing the full text, typical patterns include:
- Compound Claims: If the patent covers a new chemical entity, claims specify the chemical structure, stereochemistry, or polymorph.
- Use Claims: Claims may specify a particular therapeutic application, such as treatment of an immune disorder or cancer.
- Formulation Claims: These could detail controlled-release formulations, stabilizers, or dosage parameters.
- Process Claims: Methods of synthesis or purification may be claimed to prevent competitors from reproducing similar compounds.
c. Scope Analysis
The degree of claim broadness directly influences patent strength:
- Broad Claims: Encompass a wide chemical class or therapeutic area, offering extensive protection but potentially vulnerable to prior art challenges.
- Narrow Claims: Focus on specific compounds or uses, providing limited but more defensible protection.
Given typical strategy, the patent likely balances broad compound claims with narrower, use-specific claims to maximize coverage.
3. Patent Landscape Context
a. Existing Patent Environment in South Korea
South Korea maintains a highly active pharmaceutical patent landscape, characterized by:
- Numerous patents on chemical entities, formulations, and therapeutic methods.
- Heavy scrutiny of chemical and medical process patents for novelty and inventive step.
- Active patenting by domestic companies (e.g., Samsung Biologics, SK Bioscience) and international entrants.
b. Related Patents and Art
The patent landscape probably includes:
- Prior Art Search: Previous patents covering similar chemical classes or therapeutic targets, especially from Asian jurisdictions and global patent databases.
- Patent Families: Related filings in the US, Europe, and China, aimed at global protection.
- Patent Thickets: Dense clusters of overlapping patents, particularly in fields like oncology, immunology, or biologics, which could pose infringement risks.
c. Potential Overlaps and Freedom-to-Operate (FTO)
Critical considerations involve cross-referencing KR20240036132’s claims with existing patents to gauge overlap. Overlaps in chemical structures or use claims may limit commercialization freedom unless licensing or design-around strategies are employed.
4. Patent Strength and Legal Considerations
a. Novelty and Inventive Step
The patent’s validity depends on demonstrating that its claimed invention:
- Is novel, i.e., not disclosed anywhere prior to the filing date.
- Involves an inventive step, meaning it’s non-obvious to someone skilled in the art.
If prior art documents disclose similar compounds or methods, the patent’s broad claims might be challenged.
b. Patent Term and Maintenance
Standard patent life in South Korea is 20 years from filing, renewable annually. Effective maintenance and enforcement are essential for sustained value.
c. Potential Challenges
Existing patents and literature could be raised by competitors or patent offices during examination, especially if claims are broad. The patent applicant may need to defend against re-examination or opposition proceedings.
5. Strategic Implications
- Protection Scope: Broad claims covering a class of compounds or uses can secure dominant market positioning.
- Potential Licensing Opportunities: Overlapping patents or collaborations could open licensing avenues.
- Competitive Risks: Overlap with prior art or weak inventive steps can open pathways for invalidation.
6. Comparative Patent Filing Trends
Trend analysis shows increasing filings in biologics and targeted therapies in South Korea. If KR20240036132 pertains to such an area, it aligns with national innovation priorities, potentially attracting government support or research grants.
7. Regulatory and Commercial Outlook
Patent protection in South Korea synergizes with regulatory approval processes governed by the Ministry of Food and Drug Safety (MFDS). A strong patent portfolio enhances commercialization prospects, attracts licensing deals, and sustains market exclusivity.
Key Takeaways
- Scope Precision: The strength of KR20240036132 depends on carefully drafted claims balancing broad coverage with defensibility against prior art.
- Landscape Position: Its integration within the existing South Korean patent environment determines its competitive moat and potential for infringement disputes.
- Strategic Value: Broader claims targeting a specific therapeutic area or chemical class can maximize market control, but must withstand novelty and inventive step scrutiny.
- Legal Vigilance: Ongoing patent monitoring and possible infringement risk assessments are essential for leveraging the patent fully.
- Global Relevance: Due to its recent publication, extending protection via international applications amplifies the patent’s strategic value in global markets.
FAQs
1. What is the primary focus of patent KR20240036132?
The patent likely covers a novel drug formulation, an active pharmaceutical ingredient, a method of synthesis, or a specific therapeutic use—precise details depend on its claims, which aim to secure exclusive rights over these innovations.
2. How does the patent landscape in South Korea impact this patent’s strength?
A competitive environment filled with overlapping patents can challenge the patent’s validity, especially if prior art closely resembles the claimed invention. Strategic claim drafting and continuous landscape monitoring are critical.
3. Can this patent be extended or used internationally?
Yes, through pathways like the Patent Cooperation Treaty (PCT) or direct national filings in key markets such as the US, Europe, and China, to secure broader protection.
4. What are common challenges faced by similar pharmaceutical patents?
Challenges include prior art rejections during patent examination, opposition from competitors, and potential invalidation if claims are deemed overly broad or obvious.
5. How does this patent influence the commercialization of the associated drug?
A robust patent secures market exclusivity, facilitates licensing deals, and deters infringers, enhancing commercial success and return on R&D investment.
References
- South Korea Intellectual Property Office (KIPO) Patent Database.
- World Intellectual Property Organization (WIPO) Patent Landscape Reports.
- Relevant South Korean patent laws and regulations.
- Industry reports on pharmaceutical patent trends in Asia.
